Clinical Trial Update: Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluates combination chemotherapy followed by filgrastim or sargramostim in patients with relapsed or refractory acute myeloid leukemia or acut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Filgrastim (filgrastim)
• sargramostim (sargramostim)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Leukemia | Phase 2 | Status: COMPLETED